Wikidata

(Q43919322)

English

Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells

scientific article published in March 2004

In more languages

Statements

title
Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
author name string
James A Bonner
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
Donald J Buchsbaum
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
Buck E Rogers
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
William E Grizzle
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
Hoa Q Trummell
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
Roger Ove
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
Kevin P Raisch
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
publication date
1 March 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017
page(s)
950-958
1 reference
stated in
Europe PubMed Central
PubMed ID
14967455
retrieved
28 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43919322&oldid=2149820543"